{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:52Z","timestamp":1787032852207,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,13]]},"DOI":"10.7759\/cureus.66784","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T12:31:15Z","timestamp":1723552275000},"source":"Crossref","is-referenced-by-count":3,"title":["Uric Acid as a Biomarker for Mood Disorders: A Comparative Study of Blood Uric Acid Levels Correlating With the Symptom Severity and Treatment Response"],"prefix":"10.7759","author":[{"given":"Sylviah","family":"Immanuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Kaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya Rachel","family":"Jetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha Manaswini","family":"Vupputuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramireddy","family":"K V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul Saravanan","family":"R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: a Swedish national cohort study","volume":"70","author":"Crump C","year":"2013","unstructured":"Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry. 2013, 70:931-9. 10.1001\/jamapsychiatry.2013.1394","journal-title":"JAMA Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham LN","year":"2018","unstructured":"Yatham LN, Kennedy SH, Parikh SV, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018, 20:97-170. 10.1111\/bdi.12609","journal-title":"Bipolar Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X14666160606210811","article-title":"Depression and mania in bipolar disorder","volume":"15","author":"Tondo L","year":"2017","unstructured":"Tondo L, V\u00e1zquez GH, Baldessarini RJ. Depression and mania in bipolar disorder. Curr Neuropharmacol. 2017, 15:353-8. 10.2174\/1570159X14666160606210811","journal-title":"Curr Neuropharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318268391d","article-title":"Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania","volume":"32","author":"Machado-Vieira R","year":"2012","unstructured":"Machado-Vieira R. Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania. J Clin Psychopharmacol. 2012, 32:735-6. 10.1097\/JCP.0b013e318268391d","journal-title":"J Clin Psychopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2016.09.011","article-title":"Purinergic system dysfunctions in subjects with bipolar disorder: a comparative cross-sectional study","volume":"73","author":"Bartoli F","year":"2017","unstructured":"Bartoli F, Crocamo C, Dakanalis A, et al.. Purinergic system dysfunctions in subjects with bipolar disorder: a comparative cross-sectional study. Compr Psychiatry. 2017, 73:1-6. 10.1016\/j.comppsych.2016.09.011","journal-title":"Compr Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-023-00450-5","article-title":"Study on association of serum uric acid levels with bipolar disorder: systematic review and meta-analysis in Chinese patients","volume":"22","author":"Chen H","year":"2023","unstructured":"Chen H, Sun F, Jin W. Study on association of serum uric acid levels with bipolar disorder: systematic review and meta-analysis in Chinese patients. Ann Gen Psychiatry. 2023, 22:20. 10.1186\/s12991-023-00450-5","journal-title":"Ann Gen Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97955-4","article-title":"Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study","volume":"11","author":"Lu Z","year":"2021","unstructured":"Lu Z, Wang Y, Xun G. Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study. Sci Rep. 2021, 11:18307. 10.1038\/s41598-021-97955-4","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s43045-023-00307-3","article-title":"Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder","volume":"31","author":"Shaker NM","year":"2023","unstructured":"Shaker NM, Serafi DE, Mahfouz R, et al.. Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder. Middle East Curr Psychiatry. 2023, 31:1-8. 10.1186\/s43045-023-00307-3","journal-title":"Middle East Curr Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229626","article-title":"Serum uric acid a depression biomarker","volume":"4","author":"Meng X","year":"2020","unstructured":"Meng X, Huang X, Deng W, Li J, Li T. Serum uric acid a depression biomarker. PLoS One. 2020, 4:7055893. 10.1371\/journal.pone.0229626","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6612.21.02204-1","article-title":"A comparison of serum uric acid levels across different affective disorders","volume":"63","author":"Teixeira D","year":"2022","unstructured":"Teixeira D, Marques A, Barbosa P, et al.. A comparison of serum uric acid levels across different affective disorders. Minerva Psychiatry. 2022, 63:152-8. 10.23736\/S2724-6612.21.02204-1","journal-title":"Minerva Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.188","article-title":"Purinergic system in psychiatric diseases","volume":"23","author":"Cheffer A","year":"2018","unstructured":"Cheffer A, Castillo AR, Corr\u00eaa-Velloso J, et al.. Purinergic system in psychiatric diseases. Mol Psychiatry. 2018, 23:94-106. 10.1038\/mp.2017.188","journal-title":"Mol Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2605","article-title":"Purinergic signalling and disorders of the central nervous system","volume":"7","author":"Burnstock G","year":"2008","unstructured":"Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov. 2008, 7:575-90. 10.1038\/nrd2605","journal-title":"Nat Rev Drug Discov"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1054\/mehy.2001.1543","article-title":"Purinergic dysfunction in mania: an integrative model","volume":"58","author":"Machado-Vieira R","year":"2002","unstructured":"Machado-Vieira R, Lara DR, Souza DO, Kapczinski F. Purinergic dysfunction in mania: an integrative model. Med Hypotheses. 2002, 58:297-304. 10.1054\/mehy.2001.1543","journal-title":"Med Hypotheses"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2527","article-title":"Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies","volume":"100","author":"Yuan H","year":"2015","unstructured":"Yuan H, Yu C, Li X, et al.. Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab. 2015, 100:4198-207. 10.1210\/jc.2015-2527","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.11613\/bm.2012.007","article-title":"Uric acid as one of the important factors in multifactorial disorders--facts and controversies","volume":"22","author":"Pasalic D","year":"2012","unstructured":"Pasalic D, Marinkovic N, Feher-Turkovic L. Uric acid as one of the important factors in multifactorial disorders--facts and controversies. Biochem Med (Zagreb). 2012, 22:63-75. 10.11613\/bm.2012.007","journal-title":"Biochem Med (Zagreb)"},{"key":"ref16","article-title":"Icd-10: International Statistical Classification of Diseases and Related Health Problems: Tenth Revision","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Icd-10: International Statistical Classification of Diseases and Related Health Problems: Tenth Revision. Pan American Health Organization, Czech; 2004."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young RC","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978, 133:429-35. 10.1192\/bjp.133.5.429","journal-title":"Br J Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton M","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960, 23:56-62. 10.1136\/jnnp.23.1.56","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5812\/archneurosci.30236","article-title":"Serum uric acid levels in different phases of acute severe manic and depressed patients","volume":"3","author":"Keshavarz M","year":"2016","unstructured":"Keshavarz M, Khosravizadegan F, Bibak A. Serum uric acid levels in different phases of acute severe manic and depressed patients. Arch Neurosci. 2016, 3:1-6. 10.5812\/archneurosci.30236","journal-title":"Arch Neurosci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.02.027","article-title":"Increased uric acid levels in drug-na\u00efve subjects with bipolar disorder during a first manic episode","volume":"34","author":"Salvadore G","year":"2010","unstructured":"Salvadore G, Viale CI, Luckenbaugh DA, et al.. Increased uric acid levels in drug-na\u00efve subjects with bipolar disorder during a first manic episode. Prog Neuropsychopharmacol Biol Psychiatry. 2010, 34:819-21. 10.1016\/j.pnpbp.2010.02.027","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.11.005","article-title":"Increased uric acid levels in bipolar disorder subjects during different phases of illness","volume":"173","author":"Albert U","year":"2015","unstructured":"Albert U, De Cori D, Aguglia A, Barbaro F, Bogetto F, Maina G. Increased uric acid levels in bipolar disorder subjects during different phases of illness. J Affect Disord. 2015, 173:170-5. 10.1016\/j.jad.2014.11.005","journal-title":"J Affect Disord"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e222","article-title":"Comparison of serum uric acid in major depressive disorder and bipolar disorder: a retrospective chart review study","volume":"35","author":"Kim S","year":"2020","unstructured":"Kim S, Rhee SJ, Song Y, Ahn YM. Comparison of serum uric acid in major depressive disorder and bipolar disorder: a retrospective chart review study. J Korean Med Sci. 2020, 35:e222. 10.3346\/jkms.2020.35.e222","journal-title":"J Korean Med Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00934-0","article-title":"The purinergic system as a target for the development of treatments for bipolar disorder","volume":"36","author":"Gon\u00e7alves MCB","year":"2022","unstructured":"Gon\u00e7alves MCB, Andrejew R, Gubert C. The purinergic system as a target for the development of treatments for bipolar disorder. CNS Drugs. 2022, 36:787-801. 10.1007\/s40263-022-00934-0","journal-title":"CNS Drugs"},{"key":"ref24","article-title":"Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder","volume":"22","author":"De Berardis D","year":"2008","unstructured":"De Berardis D, Conti CM, Campanella D, et al.. Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder. J Biol Regul Homeost Agents. 2008, 22:195-200.","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2018.04.030","article-title":"Serum uric acid levels in first episode mania, effect on clinical presentation and treatment response: Data from a case control study","volume":"35","author":"Chatterjee SS","year":"2018","unstructured":"Chatterjee SS, Ghosal S, Mitra S, Mallik N, Ghosal MK. Serum uric acid levels in first episode mania, effect on clinical presentation and treatment response: Data from a case control study. Asian J Psychiatr. 2018, 35:15-7. 10.1016\/j.ajp.2018.04.030","journal-title":"Asian J Psychiatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-010-0016-z","article-title":"Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder","volume":"25","author":"Chaudhari K","year":"2010","unstructured":"Chaudhari K, Khanzode S, Khanzode S, Dakhale G, Saoji A, Sarode S. Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder. Indian J Clin Biochem. 2010, 25:77-81. 10.1007\/s12291-010-0016-z","journal-title":"Indian J Clin Biochem"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.04.053","article-title":"Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder: the role of affective temperament","volume":"165","author":"Kesebir S","year":"2014","unstructured":"Kesebir S, Tatl\u0131dil Yaylac\u0131 E, S\u00fcner O, G\u00fcltekin BK. Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder: the role of affective temperament. J Affect Disord. 2014, 165:131-4. 10.1016\/j.jad.2014.04.053","journal-title":"J Affect Disord"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-673692300-3","article-title":"Uric-acid metabolism in manic-depressive illness and during lithium therapy","volume":"1","author":"Anumonye A","year":"1968","unstructured":"Anumonye A, Reading HW, Knight F, Ashcroft GW. Uric-acid metabolism in manic-depressive illness and during lithium therapy. Lancet. 1968, 1:1290-3. 10.1016\/s0140-673692300-3","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2014.11.038","article-title":"Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium","volume":"225","author":"Muti M","year":"2015","unstructured":"Muti M, Del Grande C, Musetti L, et al.. Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium. Psychiatry Res. 2015, 225:604-8. 10.1016\/j.psychres.2014.11.038","journal-title":"Psychiatry Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2014.05.013","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder","volume":"24","author":"Jahangard L","year":"2014","unstructured":"Jahangard L, Soroush S, Haghighi M, Ghaleiha A, Bajoghli H, Holsboer-Trachsler E, Brand S. In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder. Eur Neuropsychopharmacol. 2014, 24:1210-21. 10.1016\/j.euroneuro.2014.05.013","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/271648-uric-acid-as-a-biomarker-for-mood-disorders-a-comparative-study-of-blood-uric-acid-levels-correlating-with-the-symptom-severity-and-treatment-response","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T12:31:18Z","timestamp":1723552278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/271648-uric-acid-as-a-biomarker-for-mood-disorders-a-comparative-study-of-blood-uric-acid-levels-correlating-with-the-symptom-severity-and-treatment-response"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.66784","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,13]]}}}